Vetter - Microdermics Agreement

Vetter, a leading and innovative provider of aseptic prefilled drug delivery systems and Microdermics Inc., a Vancouver-based medical device company developing a novel hollow, metal microneedle drug and vaccine delivery system, have entered into a strategic cooperation agreement.

"We believe that microneedles are a particularly innovative technology and may prove to be a promising future alternative for selected areas of drug delivery." said Dr. Claus Feussner, Vetter's Senior Vice President Development Service.

"Microdermics is extremely excited to work with a world-class partner like Vetter, since our strategic interests align and their decades of experience and innovation in the fill and finish segment will enable us to accelerate our commercialization strategy. Vetter's vast experience with a wide variety of drug substances provides us with an invaluable opportunity for a successful development path for our microneedle drug delivery technology," said Grant Campany, President & CEO of Microdermics.   To read the entire press release, click here.

Posted in: